Trials / Completed
CompletedNCT00641719
A Long-term Study for the Treatment of Painful Diabetic Neuropathy
A Superiority Study of LY248686 Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain - Extension Phase
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 258 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to investigate safety and efficacy of duloxetine for patients with painful diabetic neuropathy at long-term use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine hydrochloride | Duloxetine 40 mg QD, PO, 1 year |
| DRUG | Duloxetine hydrochloride | Duloxetine 60 mg QD, PO, 1 year |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2008-03-24
- Last updated
- 2011-03-31
- Results posted
- 2011-03-31
Locations
25 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00641719. Inclusion in this directory is not an endorsement.